Conestoga Capital Advisors’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,118,869
| Closed | -$82.4M | – | 130 |
|
|
2023
Q2 | $82.4M | Sell |
1,118,869
-12,616
| -1% | -$851K | 1.31% | 34 |
|
|
2023
Q1 | $66.4M | Sell |
1,131,485
-482,855
| -30% | -$26.6M | 1.11% | 37 |
|
|
2022
Q4 | $81.4M | Sell |
1,614,340
-55,983
| -3% | -$3.36M | 1.52% | 29 |
|
|
2022
Q3 | $145M | Sell |
1,670,323
-9,505
| -0.6% | -$999K | 2.84% | 8 |
|
|
2022
Q2 | $191M | Sell |
1,679,828
-11,510
| -0.7% | -$1.32M | 3.47% | 4 |
|
|
2022
Q1 | $219M | Buy |
1,691,338
+188,112
| +13% | +$27.1M | 3.3% | 5 |
|
|
2021
Q4 | $271M | Buy |
1,503,226
+801
| +0.1% | +$139K | 3.53% | 2 |
|
|
2021
Q3 | $223M | Buy |
1,502,425
+55,400
| +4% | +$8.49M | 3.09% | 8 |
|
|
2021
Q2 | $219M | Buy |
1,447,025
+3,710
| +0.3% | +$517K | 3.17% | 2 |
|
|
2021
Q1 | $187M | Sell |
1,443,315
-174,067
| -11% | -$22.3M | 2.82% | 6 |
|
|
2020
Q4 | $194M | Buy |
1,617,382
+20,140
| +1% | +$1.98M | 3.09% | 2 |
|
|
2020
Q3 | $119M | Buy |
1,597,242
+93,387
| +6% | +$6.47M | 2.41% | 15 |
|
|
2020
Q2 | $106M | Sell |
1,503,855
-161,905
| -10% | -$11.1M | 2.31% | 17 |
|
|
2020
Q1 | $109M | Buy |
1,665,760
+88,016
| +6% | +$7.01M | 3.2% | 5 |
|
|
2019
Q4 | $129M | Sell |
1,577,744
-3,162
| -0.2% | -$243K | 3.1% | 3 |
|
|
2019
Q3 | $114M | Buy |
1,580,906
+5,245
| +0.3% | +$385K | 2.92% | 5 |
|
|
2019
Q2 | $136M | Buy |
1,575,661
+29,493
| +2% | +$2.4M | 3.39% | 4 |
|
|
2019
Q1 | $125M | Buy |
1,546,168
+15,353
| +1% | +$1.15M | 3.48% | 3 |
|
|
2018
Q4 | $93.7M | Sell |
1,530,815
-530,093
| -26% | -$35.9M | 2.99% | 3 |
|
|
2018
Q3 | $148M | Buy |
2,060,908
+227,685
| +12% | +$14.3M | 3.78% | 2 |
|
|
2018
Q2 | $96.2M | Buy |
1,833,223
+98,515
| +6% | +$4.63M | 3.1% | 4 |
|
|
2018
Q1 | $75.3M | Sell |
1,734,708
-57,605
| -3% | -$2.65M | 2.88% | 5 |
|
|
2017
Q4 | $86.9M | Buy |
1,792,313
+174,607
| +11% | +$8.81M | 3.34% | 2 |
|
|
2017
Q3 | $82.6M | Buy |
1,617,706
+11,105
| +0.7% | +$532K | 3.65% | 1 |
|
|
2017
Q2 | $69.2M | Buy |
1,606,601
+92,735
| +6% | +$3.85M | 3.6% | 1 |
|
|
2017
Q1 | $61.5M | Buy |
1,513,866
+172,642
| +13% | +$6.36M | 3.72% | 1 |
|
|
2016
Q4 | $45.5M | Sell |
1,341,224
-168,835
| -11% | -$5.81M | 3.03% | 6 |
|
|
2016
Q3 | $57.8M | Buy |
1,510,059
+36,325
| +2% | +$1.35M | 3.96% | 1 |
|
|
2016
Q2 | $50.4M | Sell |
1,473,734
-269,035
| -15% | -$8.39M | 3.73% | 1 |
|
|
2016
Q1 | $48.6M | Buy |
1,742,769
+400,400
| +30% | +$11M | 3.28% | 5 |
|
|
2015
Q4 | $41.7M | Sell |
1,342,369
-57,777
| -4% | -$1.7M | 3.37% | 6 |
|
|
2015
Q3 | $43.5M | Sell |
1,400,146
-33,071
| -2% | -$1.18M | 3.49% | 3 |
|
|
2015
Q2 | $54M | Sell |
1,433,217
-20,575
| -1% | -$750K | 3.75% | 1 |
|
|
2015
Q1 | $51M | Sell |
1,453,792
-42,115
| -3% | -$1.39M | 3.49% | 2 |
|
|
2014
Q4 | $49.5M | Sell |
1,495,907
-55,001
| -4% | -$1.7M | 3.45% | 2 |
|
|
2014
Q3 | $42.4M | Buy |
1,550,908
+15,535
| +1% | +$426K | 3.1% | 3 |
|
|
2014
Q2 | $44.1M | Sell |
1,535,373
-21,118
| -1% | -$570K | 2.96% | 5 |
|
|
2014
Q1 | $44.5M | Buy |
1,556,491
+188,718
| +14% | +$5.16M | 2.82% | 6 |
|
|
2013
Q4 | $34.9M | Buy |
1,367,773
+239,340
| +21% | +$5.72M | 2.35% | 16 |
|
|
2013
Q3 | $26.7M | Buy |
1,128,433
+710,902
| +170% | +$15.8M | 2.29% | 16 |
|
|
2013
Q2 | $8.58M | Buy |
+417,531
| New | +$7.71M | 0.89% | 43 |
|
Other funds holding OMCL
CIP
CS
GCM
Conestoga Capital Advisors's OMCL Position: Q3 2023 in Review
Conestoga Capital Advisors sold out of Omnicell (OMCL) in Q3 2023, closing a stake of 1,118,869 shares — an estimated $82.4M sold.
Conestoga Capital Advisors first reported a position in OMCL in Q2 2013 and held it in 41 quarters. The position peaked at $271M in Q4 2021. 312 funds tracked by Wall St. Rank hold OMCL as of Q3 2023.
- Conestoga Capital Advisors reported no remaining Omnicell position as of Q3 2023 after selling out during the quarter.
- Conestoga Capital Advisors sold 1,118,869 Omnicell shares in Q3 2023, an estimated $82.4M.
- Conestoga Capital Advisors first reported a position in Omnicell in Q2 2013 and held it in 41 quarters.
- Conestoga Capital Advisors's Omnicell position peaked at $271M in Q4 2021.
- 312 funds tracked by Wall St. Rank held Omnicell as of Q3 2023.
Based on Conestoga Capital Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.